A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. (OCHTQ.PK). Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.
The message board for Orchestra on yahoo is still active under OCHTQ. There doesn't seem to be much progress being made for Immune Response Biopharma other than changes on their website.